Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Plasmacytoma × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 5 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Prostatic Neoplasms 1 Plasmacytoma 1 Neoplasms, Plasma Cell 1 Neoplasms 1 Melanoma 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Carcinoma, Renal Cell 1 Amyloidosis 1

Interventions

milatuzumab 1 filanesib 1 Thalidomide 1 Steroids 1 Injections, Subcutaneous 1 Immunotherapy, Adoptive 1 Granulocyte Colony-Stimulating Factor 1 Filgrastim 1 Dexamethasone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00081757 2010-07-02

An Open Protocol for the Compassionate Use of Thalidomide

University of Arkansas

Phase 1/2 Completed

Multiple Myeloma, Plasmacytoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡